Filter by
Filter by
Treating thoracic cancers with proton therapy
Worldwide, lung cancer is the most common cancer among men in both incidence and...
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis.
This study by the Sloan Kettering group, New York, reported the results of a randomized phase II trial comparing Photon involved-field radiotherapy (IFRT) and...
Hypofractionated proton therapy for non-small cell lung cancer: Ready for prime time? A systematic review and meta-analysis.
This systematic review evaluated eight studies and 401 patients with early stage NSCLC treated with hypofractionated PBT to a median total dose of 63 Gy(RBE)...
Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.
163 consecutively treated patients with biopsy-proven, stage III NSCLC who received IMPT (n = 35, 21%) or IMRT (n = 128, 79%) were analyzed in this study...